Skip to content
Shuttingdown

AMICUS THERAPEUTICS, INC.

Pharmaceutical Preparations · PRINCETON · NJ

No longer listed

High confidence (85%)

Updated Oct 18, 2026, 12:03 AM

What is happening

Derived by rule set status-rules-2026.09.7

The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

Latest material event: AMICUS THERAPEUTICS, INC. deregistered its securities (May 7, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. AMICUS THERAPEUTICS, INC. deregistered its securities

    May 7, 2026

    Registration withdrawn

    • SEC EDGAR — “15-12G 1 ef20072674_1512g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-33497 Amicus Therapeutics, Inc. (Exact name of registrant as specified in its charter) 47 Hulfish Street, Princeton, NJ 08542 (609) 662-2000 (Address, including zip code, and telephone number, including area code, of registrant s princ…”

  2. AMICUS THERAPEUTICS, INC. received a delisting notice from its exchange

    Apr 27, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01, Item 3.03, Item 5.01, Item 5.02 and Item 5.03 are incorporated herein by reference. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The disclosures under the Introductory Note are incorporated herein by reference. On April 27, 2026, the Company (i) notified the Nasdaq Global Select Market ( Nasdaq ) of the consummation of the Merger and its intent to remove all Company Common Stock from Nasdaq and (ii) requested that Nasdaq (A) halt trading of Company Common Stock effective before the opening of trading on and continuing…”

  3. AMICUS THERAPEUTICS, INC. was delisted from its exchange

    Apr 27, 2026

    Delisting effective

    • SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001178879 AMICUS THERAPEUTICS, INC. 001-33497 1 Cedar Brook Drive Cranbury NJ NEW JERSEY 08512 +1 609 662-2000 Common Stock 17 CFR 240.12d2-2(a)(3) Tara Petta AVP 2026-04-27”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
SEC CIK
0001178879
Website
—
LinkedIn
—
Headquarters
PRINCETON, NJ
Also known as
AMICUS THERAPEUTICS INC
Legal entities
AMICUS THERAPEUTICS, INC.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    AMICUS THERAPEUTICS, INC. — Pharmaceutical Preparations (SIC 2834) — PRINCETON, NJ
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    15-12G 1 ef20072674_1512g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-33497 Amicus Therapeutics, Inc. (Exact name of registrant as specified in its charter) 47 Hulfish Street, Princeton, NJ 08542 (609) 662-2000 (Address, including zip code, and telephone number, including area code, of registrant s princ…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    X0203 0001354457 Nasdaq Stock Market LLC 0001178879 AMICUS THERAPEUTICS, INC. 001-33497 1 Cedar Brook Drive Cranbury NJ NEW JERSEY 08512 +1 609 662-2000 Common Stock 17 CFR 240.12d2-2(a)(3) Tara Petta AVP 2026-04-27
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01, Item 3.03, Item 5.01, Item 5.02 and Item 5.03 are incorporated herein by reference. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The disclosures under the Introductory Note are incorporated herein by reference. On April 27, 2026, the Company (i) notified the Nasdaq Global Select Market ( Nasdaq ) of the consummation of the Merger and its intent to remove all Company Common Stock from Nasdaq and (ii) requested that Nasdaq (A) halt trading of Company Common Stock effective before the opening of trading on and continuing…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:31 AM

    The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:04 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:02 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:35 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.